Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...

A recent study published in the journal Frontiers in Endocrinology investigated the role of the short-chain dehydrogenase/reductase 42E member 1 (SDR42E1) enzyme in regulating sterol metabolism and ...

Real-world data reinforces the efficacy and tolerability of lenvatinib and pembrolizumab for treating recurring endometrial cancer.

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

The combination of ribociclib and letrozole achieved a 30.6% objective response rate and 84% clinical benefit rate in ...

Sweeney won the Top Presentation Award for his talk titled, “The SUMO Balancing Act: Insights into Cellular Robustness from ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

The mountains, valleys and islands of Washington state are renowned for their natural beauty. But for those dealing with cancer (or trying their best to avoid it!), these magnificent physical features ...